Skip to main content
Equibles

CMND · Clearmind Medicine Inc. · Metrics

Track CMND — free

Use CMND with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CMND.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$5.73 -0.27 (-4.50%)
Rebalance outlook locked
Market Cap
$24.36M
Shares
4.06M
Volume · Oct 6 29.13K Avg daily vol (1 sessions) 92.04K

CMND metrics

36 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$6.00
Market cap
$24.36M

Price action

20 metrics
Price change (1W)
-11.0%
Price change (30D)
-30.6%
Price change (3M)
-69.7%
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
141.9%
Annualized volatility (3M)
104.9%
Beta
—
RSI (14D)
26.6
Price vs SMA 50
-48.2%
Price vs SMA 200
—
Avg volume (3M)
675,094
Relative volume
0.2
Average dollar volume
$1.02M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
4.06M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
0.3
reciprocal yield 298.3%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-240.4%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
−$6.64M
Trailing 12 months
Diluted EPS (TTM)
$-1,929.60
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$2,331.47

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+20,968.3%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-80.6%
Return on assets
-59.6%
Debt / equity
—
Current ratio
3.8
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
3.8
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$9.26M
Total assets
$11.14M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$5.55M
Capital expenditures (TTM)
—
R&D (TTM)
$2.24M
SG&A (TTM)
—
Stock compensation (TTM)
$1.41M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
6
13F filer change QoQ
+1
Institutional ownership
0.2%

Short interest

3 metrics
Short interest
0.1%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
36 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1892500 CUSIP 185053600 Visit website Investor relations